Syncope

Current Problems in Cardiology

Volumn 29, Issue 4, 2004, Pages 152-229

  Benditt, David G ^a,b   Van Dijk, J Gert ^c   Sutton, Richard ^a   Wieling, Wouter ^c   Lin, Joseph C ^c   Sakaguchi, Scott ^c   Lu, Fei ^c  

^a MEDTRONIC INC   (United States)

^b Cardionet Inc

^c Medtronic Inc ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DISOPYRAMIDE; EPHEDRINE; ETILEFRINE; FLUDROCORTISONE; MIDODRINE; SCOPOLAMINE; THEOPHYLLINE;

ANAMNESIS; ARTIFICIAL HEART PACEMAKER; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CAROTID SINUS SYNDROME; CATAPLEXY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; HEAD INJURY; HEAD TILTING; HEART ARRHYTHMIA; HUMAN; HYPERVENTILATION SYNDROME; HYPOTENSION; INJURY; LUNG DISEASE; MENTAL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT POSITIONING; PHYSICAL EXAMINATION; PREVALENCE; REVIEW; SEIZURE; SYNCOPE;

EID: 1942453253     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2003.12.002     Document Type: Article

References (156)

1. Brignole M., Alboni P., Benditt D.G., Bergfeldt L., Blanc J.J., Bloch P.E., et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 22:2001;1256-1306.
2. Blanc J.-J., Benditt D.G. Syncope definition, classification, and multiple potential causes. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope a handbook for clinical practice. 2003;3-10 Futura/Blackwell, Elmsford (NY).
3. Blanc J.-J., L'Her C., Touiza A., Garo B., L'Her E., Marsourati J. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J. 23:2002;815-820.
4. Disertori M., Brignole M., Menozzi C., Raviele A., Alboni P., Pitzalis M.V., et al. Management of patients with syncope referred urgently to general hospitals. Europace. 5:2003;1-9.
5. Martin G.J., Adams S.L., Martin H.G., Mathews J., Zull D., Scanlon P.J. Prospective evaluation of syncope. Ann Emerg Med. 13:1984;499-504.
6. Lamb L., Green H.C., Combs J.J., Cheesman S.A., Hammond J. Incidence of loss of consciousness in 1980 Air Force personnel. Aerospace Med. 12:1960;973-988.
7. Day S.C., Cook E.F., Funkenstein H., Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 73:1982;15-23.
8. Savage D.D., Corwin L., McGee D.L., Kannel W.B., Wolf P.A. Epidemiologic features of isolated syncope the Framingham study. Stroke. 16:1985;626-629.
9. Lipsitz L.A., Pluchino F.C., Wei J.Y., Rowe J.W. Syncope in an elderly institutionalized population prevalence, incidence and associated risk. Q J Med. 55:1985;45-54.
10. Feruglio G.A., Perraro F. Rilievi epidemiologici sulla sincope nella popolazione generale e come causa di ricovero. G Ital Cardiol. 17:1987;11-13.
11. Morichetti A., Astorino G. Epidemiological and clinical findings in 697 syncope events. Minerva Med. 89:1998;211-220.
12. Lewis D.A., Dhala A. Syncope in the pediatric patient the cardiologist's perspective. Pediatr Clin North Am. 46:1999;205-219.
13. Sarasin F.P., Louis-Simonet M., Carballo D., Slama S., Rajeswaran A., Metzger J., et al. Prospective evaluation of patients with syncope a population-based study. Am J Med. 111:2001;177-184.
14. Soteriades E.S., Evans J.C., Larson M.G., Chen M.H., Chen L., Benjamin E.J., et al. Incidence and prognosis of syncope. N Engl J Med. 347:2002;878-885.
15. Kapoor W. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 69:1990;160-175.
16. Ammirati F., Colivicchi F., Santini M. Diagnosing syncope in clinical practice implementation of a simplified diagnostic algorithm in a multicentre prospective trial-the OESIL 2 study (observatorio epidemiologico della sincope nel lazio). Eur Heart J. 21:2000;935-940.
17. Hainsworth R. Syncope and fainting. Mathias C.J., Bannister R. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 1999;429-436 Oxford University Press, Oxford.
18. Lempert T., Bauer M., Schmidt D. Syncope a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol. 36:1994;233-237.
19. Wieling W., van Dijk J.G., van Lieshout J.J., Benditt D.G. Pathophysiology and clinical presentation. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope: a handbook for clinical practice. 2003;11-22 Futura/Blackwell, Elmsford (NY).
20. Van Lieshout J.J., Wieling W., Karemaker J.M., Eckberg D. The vasovagal response. Clin Sci. 81:1991;575-586.
21. Van Dijk J.G. Fainting in animals. Clin Auton Res. 13:2003;247-255.
22. Van Lieshout J.J., Wieling W., Karemaker J.M., Secher N.H. Syncope, cerebral perfusion, and oxygenation. J Appl Physiol. 94:2003;833-848.
23. Scheinberg P., Blackburn I., Rich M., et al. Effects of aging on cerebral circulation and metabolism. Arch Neurol Psych. 70:1953;77-85.
24. Rowell L.B. Cerebral and coronary circulations. Rowell L.B. Human cardiovascular control. 1993;117-136 Oxford University Press, New York.
25. Rowell L.B. Adjustments to upright posture and blood loss. Rowell L.B. Human cardiovascular control. 1993;137-173 Oxford University Press, New York.
26. Mathias C.J., Deguchi K., Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet. 357:2001;348-353.
27. Mathias C.J. To stand on one's own legs. Clin Med. 2:2002;237-245.
28. Smit A.A.J., Halliwill J.R., Low P.A., Wieling W. Topical review pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 519:1999;1-10.
29. Grubb B.P., Gerard G., Roush K., Temesy-Armos P., Montford P., Elliott L., et al. Cerebral vasoconstriction during head-up tilt-induced vasovagal syncope a paradoxic and unexpected response. Circulation. 84:1991;1157-1164.
30. Benditt D.G., Ferguson D.W., Grubb B.P., Kapoor W.N., Kugler J., Lerman B.B., et al. Tilt table testing for assessing syncope ACC expert consensus document. J Am Coll Cardiol. 28:1996;263-275.
31. Linzer M., Yang E., Estes N.A. 3rd, Wang P., Vorperian V.R., Kapoor W.N. Clinical guideline diagnosing syncope part 1; value of history, clinical examination, and electrocardiography. Ann Intern Med. 126:1997;989-996.
32. Linzer M., Yang E., Estes N.A. 3rd, Wang P., Vorperian V.R., Kapoor W.N. Clinical guideline diagnosing syncope part 2; unexplained syncope. Ann Intern Med. 127:1997;76-86.
33. Sutton R., Brignole M. Overview of recommended diagnostic strategies. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope a handbook for clinical practice. 2003;31-37 Futura/Blackwell, Elmsford (NY).
34. Hoefnagels W.A.J., Padberg G.W., Overweg J., van der Velde E.A., Roos R.A. Transient loss of consciousness the value of the history for distinguishing seizure from syncope. J Neurol. 238:1991;39-43.
35. Calkins H., Shyr Y., Frumin H., Schork A., Morady F. The value of clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block and neurocardiogenic syncope. Am J Med. 98:1995;365-373.
36. Sutton R. Vasovagal syncope prevalence and presentation: an algorithm of management in the aviation environment. Eur Heart J. 1:1999;109-113.
37. Farwell D., Sulke N. How do we diagnose syncope? J Cardiovasc Electrophysiol. 13:2001;S9-13.
38. Alboni P., Brignole M., Menozzi C., Raviele A., Del Rosso A., Dinelli M., et al. The diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 37:2001;1921-1928.
39. Sheldon R., Rose S., Ritchie D., Connolly S., Koshman M.L., Lee M.A. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 40:2002;142-148.
40. Benditt D.G., Brignole M. Syncope is a diagnosis a diagnosis? J Am Coll Cardiol. 41:2003;791-794.
41. Kenny R.A., Ingram A., Bayliss J., Sutton R. Head-up tilt a useful test for investigating unexplained syncope. Lancet. 1:1986;1352-1355.
42. Almquist A., Goldenberg I.F., Milstein S., Chen M.Y., Chen X.C., Hansen R., et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 320:1989;346-351.
43. Fitzpatrick A.P., Theodorakis G., Vardas P., Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 17:1991;125-130.
44. Sheldon R., Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol. 19:1992;773-779.
45. Kapoor W.N., Brant N. Evaluation of syncope by upright tilt testing with isoproterenol a nonspecific test. Ann Intern Med. 116:1992;358-363.
46. Sheldon R., Splawinski J., Killam S. Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol. 69:1992;1300-1305.
47. De Buitler M., Grogan E.W. Jr, Picone M.F., Casteen J.A. Immediate reproducibility of the tilt table test in adults with unexplained syncope. Am J Cardiol. 71:1993;304-307.
48. Blanc J.J., Mansourati J., Maheu B., Boughaleb D., Genet L. Reproducibility of a positive passive upright tilt test at a seven-day interval in patients with syncope. Am J Cardiol. 72:1993;469-471.
49. Raviele A., Gasparini G., Di Pede F., Menozzi C., Brignole M., Dinelli M., et al. Nitroglycerin infusion during upright tilt a new test for the diagnosis of vasovagal syncope. Am Heart J. 127:1994;103-111.
50. Moya A., Permanyer-Miralda G., Sagrista-Sauleda J., Carne X., Rius T., Mont L., et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol. 25:1995;65-69.
51. Morillo C.A., Klein G.J., Zandri S., Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J. 129:1995;901-906.
52. Raviele S.A., Menozzi C., Brignole M., Gasparini G., Alboni P., Musso G., et al. Value of head-up tilt testing potentiated with sublingual nitriglycerin to assess the origin of unexplained syncope. Am J Cardiol. 76:1995;267-272.
53. Ammirati F., Colivicchi F., Biffi A., Magris B., Pandozi C., Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitratte a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J. 135:1998;671-676.
54. Del Rosso A., Bartoli P., Bartoletti A., Brandinelli-Geri A., Bonechi F., Maioli M., et al. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J. 135:1998;564-570.
55. Moya A., Brignole M., Menozzi C., Garcia-Civera R., Tognarini S., Mont L., et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 104:2001;1261-1267.
56. Brignole M., Menozzi C., Moya A., Garcia-Civera R., Mont L., Alvarez M., et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiologic test. Circulation. 104:2001;2045-2050.
57. Menozzi C., Brignole M., Garcia-Civera R., Moya A., Botto G., Tercedor L., et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 105:2002;2741-2745.
58. Parry S.W., Richardson D., O'Shea D., Sen B., Kenny R.A. Diagnosis of carotid sinus hypersensitivity in older adults carotid sinus massage in the upright position is essential. Heart. 83:2000;22-23.
59. Kenny R.A., Richardson D.A., Steen N., Bexton R.S., Shaw F.E., Bond J. Carotid sinus syndrome a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 38:2001;1491-1496.
60. Richardson D.A., Bexton R., Shaw F.E., Steen N., Bond J., Kenny R.A. How reproducible is the cardioinhibitory response to carotid sinus massage in fallers. Europace. 4:2002;361-364.
61. Munro N., McIntosh S., Lawson J., Morley C.A., Sutton R., Kenny R.A. The incidence of complications after carotid sinus massage in older patients with syncope. J Am Geriatr Soc. 42:1994;1248-1251.
62. Davies A.G., Kenny R.A. Neurological complications following carotid sinus massage. Am J Cardiol. 81:1998;1256-1257.
63. Flammang D., Church T., Waynberger M., Chassing A., Antiel M. Can adenosine 5'triphosphate be used to select treatment in severe vasovagal syndrome? Circulation. 96:1997;1201-1208.
64. Brignole M., Gaggioli G., Menozzi C., Gianfranchi L., Bartoletti A., Bottoni N., et al. Adenosine-induced atrioventricular block in patients with unexplained syncope the diagnostic value of ATP test. Circulation. 96:1997;3921-3927.
65. Flammang D., Chassing A., Donal E., Hamani D., Erickson M., McCarville S. Reproducibility of the 5'triphosphate test in vasovagal syndrome. J Cardiovasc Electrophysiol. 9:1998;1161-1166.
66. Flammang D., Erickson M., McCarville S., Church T., Hamani D., Donal E. Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome preliminary results and potential therapeutic implications. Circulation. 99:1999;2427-2433.
67. Low P.A. Autonomic nervous system function. J Clin Neurophysiol. 10:1993;14-27.
68. Younoszai A.K., Franklin W.H., Chan D.P., Cassidy S.C., Allen H.D. Oral fluid therapy a promising treatment for vasodepressor syncope. Arch Pediatr Adolesc Med. 152:1998;165-168.
69. Ector H., Reybrouck T., Heidbuchel H., Gewillig M., Van de Werf F. Tilt training a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol. 21:1998;193-196.
70. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., Barsotti A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents a controlled study. Circulation. 100:1999;1798-1801.
71. Krediet C.T.P., van Dijk N., Linzer M., van Lieshout J.J., Wieling W. Management of vasovagal syncope controlling or aborting faints by leg crossing and muscle tensing. Circulation. 106:2002;1684-1689.
72. Benditt D.G., Fahy G.J., Lurie G.F., Sakaguchi S., Fabian W., Samniah N. Pharmacotherapy of neurally mediated syncope. Circulation. 100:1999;1242-1248.
73. Fitzpatrick A.P., Ahmed R., Williams S., Sutton R. A randomized trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia/hypotension syndrome. Eur J Cardiac Pacing Electrophysiol. 1:1991;191-202.
74. Brignole M., Menozzi C., Gianfranchi L., Lolli G., Bottoni N., Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 70:1992;339-342.
75. Mahanonda N., Bhuripanyo K., Kangkagate C., Wansanit K., Kulchot B., Nademanee K., et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 130:1995;1250-1253.
76. Sheldon R., Rose S., Flanagan P., Koshman L., Killam S. Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 78:1996;536-539.
77. Biffi M., Boriani G., Sabbatani P., Bronzetti G., Frabetti L., Zannoli R., et al. Malignant vasovagal syncope a randomized trial of metoprolol and clonidine. Heart. 77:1997;268-272.
78. Iskos D., Dutton J., Scheinman M.M., Lurie K.G. Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol. 82:1998;1121-1124.
79. Ward C.R., Gray J.C., Gilroy J.J., Kenny R.A. Midodrine a role in the management of neurocardiogenic syncope. Heart. 79:1998;45-49.
80. Di Girolamo E., Di Iorio C., Sabatini P., Leonzio L., Barsotti A. Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia. 43:1998;833-837.
81. Raviele A., Brignole M., Sutton R., Alboni P., Giani P., Menozzi C., et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope a double-blind, randomized, placebo-controlled trial; the vasovagal syncope international study. Circulation. 99:1999;1452-1457.
82. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001;12:935-8
83. Samniah N., Sakaguchi S., Lurie K.G., Iskos D., Benditt D.G. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol. 88:2001;80-83.
84. Benditt D.G., Sutton R., Gammage M. Rate-drop response cardiac pacing for vasovagal syncope. J Interv Card Electrophysiol. 3:1999;27-33.
85. Connolly S.J., Sheldon R., Roberts R.S., Gent M. The North American vasovagal pacemaker study (VPS) a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 33:1999;16-20.
86. Sutton R., Brignole M., Menozzi C., Raviele A., Alboni P., Giani P., et al. Dual-chamber pacing in treatment of neurally mediated tilt-positive cardioinhibitory syncope pacemaker versus no therapy; a multicentre randomized study. Circulation. 102:2000;294-299.
87. Ammirati F., Colivicchi F., Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope a multicenter, randomized, controlled trial. Circulation. 104:2001;52-57.
88. Connolly S., Sheldon R., Thorpe K.E., Roberts R., Ellenbogen K.A., Wilkoff B.L., et al. Pacemaker therapy for prevention of syncope in patients with recurrent vasovagal syncope. JAMA. 289:2003;2224-2229.
89. Brignole M., Sartore B., Barra M., Menozzi C., Lolli G. Is DDD superior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-term study. Pacing Clin Electrophysiol. 11:1988;1902-1910.
90. Brignole M., Sartore B., Barra M., Menozzi C., Lolli G. Ventricular and dual chamber pacing for treatment of carotid sinus syndrome. Pacing Clin Electrophysiol. 12:1989;582-590.
91. Deschamps D., Richard A., Citron B., Chaperon A., Binon J.P., Ponsonaille J. Hypersensibilite sino-carotidienne evolution a moyen et a long terme des patients traites par stimulation ventriculaire. Arch Mal Coeur Vaiss. 83:1990;63-67.
92. Wieling W., Van Lieshout J.J., Van Leeuwen A.M. Physical maneuvers that reduce postural hypotension in autonomic failure. Clin Auton Res. 3:1993;57-65.
93. Van Lieshout J.J., Ten Harkel A.D.J., Wieling W. Combating orthostatic dizziness in autonomic failure by physical maneuvers. Lancet. 339:1992;897-898.
94. El-Sayed H., Hainsworth R. Salt supplement increases plasma volume and orthostaic tolerance in patients with unexplained syncope. Heart. 75:1996;114-115.
95. Wieling W., van Lieshout J.J., Hainsworth R. Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res. 12:2002;243-249.
96. van Lieshout J.J., Ten Harkel A.D.J., Wieling W. Physiological basis of treatment of orthostatic hypotension by sleeping head-up tilt and fludrocortisone medication. Clin Auton Res. 10:2000;35-42.
97. Moya A., Wieling W. Orthostatic syncope. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope a handbook for clinical practice. 2003;123-136 Futura/Blackwell, Elmsford (NY).
98. Tanaka H., Yamaguchi H., Tamai H. Treatment of orthostatic intolerance with inflatable abdominal band. Lancet. 349:1997;175.
99. Kardos A., Avramov K., Dongo A., Gingl Z., Kardos L., Rudas L. Management of severe orthostatic hypotension by head-up tilt posture and administration of fludrocortisone. Orv Hetil. 43:1996;2407-2411.
100. Ten Harkel A.D.J., van Lieshout J.J., Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up position, alone and in combination with fludrocortisone. J Intern Med. 232:1992;139-145.
101. McTavish D., Goa K.L. Midodrine a review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs. 38:1989;757-777.
102. Gilden J.L. Midodrine in neurogenic orthostatic hypotension. Int Angiol. 12:1993;125-131.
103. Jankovic J., Gilden J.L., Hiner B.C., Brown D.C., Rubin M. Neurogenic orthostatic hypotension a double-blind placebo-controlled study with midodrine. Am J Med. 95:1993;38-48.
104. Low P.A., Gilden J.L., Freeman R., Sheng K.-N., McElligott M.A. Efficacy of midrodrine vs placebo in neurogenic orthostatic hypotension. JAMA. 13:1997;1046-1051.
105. Benditt D.G., Milstein S., Goldstein M.A., Reyes W., Gornick C.C. Sinus node dysfunction pathophysiology, clinical features, evaluation and treatment. Zipes D.P., Jaliffe J. Cardiac electrophysiology: from cell to bedside. 1990;708-734 WB Saunders Co, Philadelphia.
106. Sgarbossa E.B., Pinski S.L., Jaeger F.J., Trohman R.G., Maloney J.D. Incidence and predictors of syncope in paced patients with sick sinus syndrome. Pacing Clin Electrophysiol. 15:1992;2055-2060.
107. Benditt D.G., Gornick C.C., Dunbar D., Almquist A. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 75:1987;93-99.
108. Gann D., Tolentino A., Samet P. Electrophysiologic evaluation of elderly patients with sinus bradycardia a long-term follow-up study. Ann Intern Med. 90:1979;24-29.
109. Morady F., Higgins J., Peters R., Schwartz A.B., Shen E.N., Bhandari A., et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol. 54:1984;587-591.
110. Kaul U., Dev V., Narula J., Malhotra A., Talwar K., Bhatia M. Evaluation of patients with bundle branch block and "unexplained" syncope a study on the basis of comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol. 11:1988;289-297.
111. McAnulty J.H., Rahimtoola S.H., Murphy E., DeMots H., Ritzmann L., Kanarek P.E., et al. Natural history of "high risk" bundle branch block final report of a prospective study. N Engl J Med. 307:1982;137-143.
112. Moya A. Cardiac arrhythmias as a primary cause of syncope. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope a handbook for clinical practice. 2003;137-153 Futura/Blackwell, Elmsford (NY).
113. Dhingra R.C., Palileo E., Strasberg B., Swiryn S., Bauerenfeind R.A., Wyndham C.R., et al. Significance of the HV interval in 517 patients with chronic bifascicular block. Circulation. 64:1981;1265-1271.
114. Scheinman M.M., Peters R.W., Sauvé M.J., Desai J., Abbott J.A., Cogan J., et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 50:1982;1316-1322.
115. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trail Investigators. N Engl J Med 1999;341:1882-90
116. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
117. Andrews N., Fogel R., Pelargonio G., Evans J., Prystowsky E. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 34:1999;2023-2030.
118. Knight B., Goyal R., Pelosi F., Flemming M., Horwood L., Morady F., et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 33:1999;1964-1970.
119. Militianu A., Salacata A., Seibert K., Kenoe R., Baga J.J., Meissner M.D., et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol. 8:1997;1087-1097.
120. Pires L.A., May L., Ravi S., Pari J.T., Lai V.R., Mino C.L. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol. 85:2000;725-728.
121. Link M.S., Costeas X.F., Griffith J.L., Colburn C.D., Estes N.A., Wang P.J. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol. 29:1997;370-375.
122. Middelkauff H.R., Stevenson W.G., Stevenson L.W., Saxon L.A. Syncope in advanced heart failure high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 21:1993;110-116.
123. Gregoratos G., Abrams J., Epstein A.E., Freedman R.A., Hayes D.L., Hlatky M.A., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices summary article. Circulation. 106:2002;2145-2161.
124. Hachiya H., Aonuma K., Yamauchi Y., Harada T., Igawa M., Nogami A., et al. Electrocardiographic characteristics of left ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 23:2000;1930-1934.
125. O'Donnell D., Cox D., Bourke J., Mitchell L., Furniss S. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J. 24:2003;801-810.
126. Daliento L., Turrini P., Nava A., Rizzoli G., Angelini A., Buja G., et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients similarities and differences. J Am Coll Cardiol. 25:1995;655-664.
127. Marcus FI, Fontaine G, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 cases. Circulation 1982;65:384-99
128. Keating M.T., Atkinson D., Dunn C., Timothy K., Vincent G.M., Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 252:1991;704-706.
129. Moss A.J., Schwartz P.J., Crampton R.S., Tzivoni D., Locati E.H., MacCluer J., et al. The long QT syndrome prospective longitudinal study of 328 families. Circulation. 84:1991;1136-1144.
130. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 392:1998;293-296.
131. Haverkamp W., Breithardt G., Camm A.J., Janse M.J., Rosen M.R., Antzelevitch C., et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs clinical and regulatory implications; report on a policy conference of the European Society of Cardiology. Eur Heart J. 21:2000;1216-1231.
132. Brugada J., Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation and sudden cardiac death. J Cardiovasc Electrophysiol. 8:1997;325-331.
133. Brugada J., Brugada P., Brugada R. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death-the Brugada syndrome. Europace. 1:1999;156-166.
134. McKenna W.J., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol. 47:1981;532-538.
135. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 342:2000;365-373.
136. Fujimura O., Yee R., Klein G., Sharma A., Boahene A. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med. 321:1989;1703-1707.
137. Crawford M.H., Bernstein S.J., Deedwania P.C., DiMarco J.P., Ferrick K.J., Garson A.J., et al. ACC/AHA guidelines for ambulatory electrocardiography. J Am Coll Cardiol. 34:1999;912-948.
138. Krahn A., Klein G.J., Yee R., Takle-Newhouse T., Norris C. Use of an extended monitoring strategy in patients with problematic syncope Reveal Investigators. Circulation. 99:1999;406-410.
139. Krahn A., Klein G.J., Yee R., Skanes A.C. Randomized assessment of syncope trial conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 104:2001;46-51.
140. Sra J.S., Anderson A.J., Sheikh S.H., Avitall B., Tchou P.J., Troup P.J., et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 114:1991;1013-1019.
141. DiMarco J.B., Garan H., Hawthorne W.J., Ruskin J.N. Intracardiac electrophysiologic techniques in recurrent syncope of unknown cause. Ann Intern Med. 95:1981;542-548.
142. Blanc J.-J., Benditt D.G. Structural cardiac and pulmonary causes of syncope. Benditt D.G., Blanc J.-J., Brignole M., Sutton R.S. The evaluation and treatment of syncope: a handbook for clinical practice. 2003;154-159 Futura/Blackwell, Elmsford (NY).
143. Dixon M.S., Thomas P., Sheridon D.J. Syncope as the presentation of unstable angina. Int J Cardiol. 19:1988;125-129.
144. Johnson A.M. Aortic stenosis, sudden death, and the left ventricular baroreceptors. Br Heart J. 33:1971;1-5.
145. Gosselin C., Walker P.M. Subclavian steal syndrome existence, clinical features, diagnosis, management. Semin Vasc Surg. 9:1996;93-97.
146. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 46:1996;1470.
147. Royal College of Physicians. Adults with poorly controlled epilepsy: clinical guidelines for treatment and practical tools for aiding epilepsy management. London: Royal College of Physicians; 1997.
148. Guideline for the prevention of falls in older persons. J Am Geriatr Soc. 49:2001;664-672.
149. Linzer M., Felder A., Hackel A., Perry A.J., Varia I., Melville M.L. Psychiatric syncope a new look at an old disease. Psychosomatics. 31:1990;181-188.
150. Linzer M., Pontinen M., Gold D.T., Divine G.W., Felder A., Brooks W.B. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 44:1991;1037-1043.
151. Grubb B.P., Gerard G., Wolfe D.A., Samoil D., Davenport C.W., Homan R.W. Syncope and seizure of psychogenic origin identification with head-upright tilt table testing. Clin Cardiol. 15:1992;839-842.
152. Kapoor W., Fortunato M., Hanusa B.H., Schulberg H.C. Psychiatric illnesses in patients with syncope. Am J Med. 99:1995;505-551.
153. Kouakam C., Lacroix D., Klug D., Baux P., Marquie C., Kacet S. Prevalence and prognostic significance of psychiatric disorders in patients evaluated for recurrent unexplained syncope. Am J Cardiol. 89:2002;530-535.
154. Kenny R.A., O'Shea D., Walker H.F. Impact of a dedicated syncope and falls facility for older adults on emergency beds. Age Ageing. 31:2002;272-275.
155. Colivicchi F., Ammirati F., Melina D., Guido V., Imperoli G., Santini M. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department the OESIL risk score. Eur Heart J. 24:2003;811-819.
156. Disertori M., Brignole M., Menozzi C., Raviele A., Rizzon P., Santini M., et al. Management of patients with syncope referred urgently to general hospitals. Europace. 5:2003;1-9.